CLL-1 and CD123 dual-target CAR-T cells

AML - Acute Myeloid Leukemia

Institute of Hematology & Blood Diseases Hospital, ChinaEarly Phase 1

—

Rating in progress

CLL-1 and CD123 dual-target CAR-T cells in AML - Acute Myeloid Leukemia is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active